Methylenedioxybenzylpiperazine

From Wikipedia, the free encyclopedia

This article does not cite any references or sources. (December 2007)
Please help improve this article by adding citations to reliable sources. Unverifiable material may be challenged and removed.



Methylenedioxybenzylpiperazine
Systematic (IUPAC) name
1-(benzo[1,3]dioxol-5-ylmethyl)piperazine
Identifiers
CAS number	32231-06-4
ATC code	?
PubChem	94426
Chemical data
Formula	C₁₂H₁₆N₂O₂
Mol. mass	220.268 g/mol
Pharmacokinetic data
Bioavailability	?
Metabolism	?
Half life	?
Excretion	?
Therapeutic considerations
Pregnancy cat.	?
Legal status
Routes	?

MDBZP (Piperonylpiperazine) or 1-(3,4-methylenedioxybenzyl)piperazine is a piperazine derivative related to the stimulant drug benzylpiperazine. In the book PIHKAL it is speculated that MDBZP might have effects similar to the drug MDMA because of the presence of the 3,4-methylenedioxy group on the benzene ring, however once the compound was tested in humans this theory was shown to be incorrect.

MDBZP has been sold as a "Research chemical" with supposed recreational properties, and has even been found as an ingredient in street "ecstasy" pills. However MDBZP is only a very mild stimulant, and does not produce euphoria, empathogenic or psychedelic effects. The prominent effects produced by MDBZP are dizziness, nausea and headaches, but at high doses it has been known to cause convulsions. MDBZP thus has all of the negative side effects of other piperazine derivatives, but without any of the positive effects that might make these drugs desirable to consumers.